Search Results - "Jung, Sara"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation by Hantel, Constanze, Shapiro, Igor, Poli, Giada, Chiapponi, Costanza, Bidlingmaier, Martin, Reincke, Martin, Luconi, Michaela, Jung, Sara, Beuschlein, Felix

    Published in Oncotarget (29-11-2016)
    “…In recent years it has been recognized that clinical translation of novel therapeutic strategies for patients with adrenocortical carcinoma (ACC) often fails…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model by Hantel, Constanze, Jung, Sara, Mussack, Thomas, Reincke, Martin, Beuschlein, Felix

    Published in Endocrine-related cancer (01-06-2014)
    “…Owing to high relapse rates and early metastatic spread, prognosis in adrenocortical carcinoma (ACC) patients remains poor, highlighting the importance of…”
    Get full text
    Journal Article
  4. 4

    Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo by Hasanovic, Anida, Ruggiero, Carmen, Jung, Sara, Rapa, Ida, Signetti, Laurie, Ben Hadj, Monia, Terzolo, Massimo, Beuschlein, Felix, Volante, Marco, Hantel, Constanze, Lalli, Enzo, Mus‐Veteau, Isabelle

    Published in International journal of cancer (01-07-2018)
    “…One of the crucial challenges in the clinical management of cancer is the resistance to chemotherapeutics. We recently demonstrated that the Hedgehog receptor…”
    Get full text
    Journal Article
  5. 5

    Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma by Jung, Sara, Nagy, Zoltan, Fassnacht, Martin, Zambetti, Gerard, Weiss, Max, Reincke, Martin, Igaz, Peter, Beuschlein, Felix, Hantel, Constanze

    Published in Endocrine-related cancer (01-10-2016)
    “…Systemic therapy of adrenocortical carcinoma (ACC) is limited by heterogeneous tumor response and adverse effects. Recently, we demonstrated anti-tumor…”
    Get full text
    Journal Article
  6. 6

    Photon TMDs from uPDFevolv by Jung, Hannes, Taheri Monfared, Sara, Wening, Thomas

    Published in SciPost physics proceedings (13-07-2022)
    “…We present photon TMDs generated using the Parton Branching Method with QED evolution. We discuss the TMD's properties and compare it to the gluon TMD. Two…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma by Beuschlein, Felix, Jakoby, Judith, Mentz, Susanne, Zambetti, Gerard, Jung, Sara, Reincke, Martin, Süss, Regine, Hantel, Constanze

    Published in Molecular and cellular endocrinology (15-06-2016)
    “…Adrenocortical carcinoma (ACC) is a tumor with poor prognosis and limited therapeutic options. Therefore, in addition to multi-chemotherapeutic regimens IGF-1…”
    Get full text
    Journal Article